These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4992354)

  • 1. Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells.
    Oldstone MB; Dixon FJ
    Virology; 1970 Dec; 42(4):805-13. PubMed ID: 4992354
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.
    Gilden DH; Cole GA; Nathanson N
    J Exp Med; 1972 Apr; 135(4):874-89. PubMed ID: 4622913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproliferative effects of lymphocytic choriomeningitis virus in germfree mice.
    Pollard M; Sharon N
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):242-6. PubMed ID: 4981173
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of anti-lymphocytic serum on murine lymphocytic choriomeningitis.
    Gledhill AW
    Nature; 1967 Apr; 214(5084):178-9. PubMed ID: 4962203
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system.
    Oldstone MB; Dixon FJ
    J Immunol; 1971 Nov; 107(5):1274-80. PubMed ID: 5000724
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus.
    Mims CA; Tosolini FA
    Br J Exp Pathol; 1969 Dec; 50(6):584-92. PubMed ID: 4391444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease.
    Cole GA; Nathanson N; Prendergast RA
    Nature; 1972 Aug; 238(5363):335-7. PubMed ID: 4561841
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.
    Doherty PC; Zinkernagel RM; Ramshaw IA
    J Immunol; 1974 Apr; 112(4):1548-52. PubMed ID: 4592605
    [No Abstract]   [Full Text] [Related]  

  • 9. Thoracic lymph duct cannulation of mice infected with lymphocytic choriomeningitis (LCM) and ectromelia viruses.
    Wallnerova Z; Mims CA
    Arch Gesamte Virusforsch; 1971; 35(2):152-60. PubMed ID: 4109491
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymus-dependent lymphocytes: destruction by lymphocytic choriomeningitis virus.
    Hanaoka M; Suzuki S; Hotchin J
    Science; 1969 Mar; 163(3872):1216-9. PubMed ID: 5765339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic preparations for the complement fixation reaction with lymphocytic choriomeningitis virus.
    Hrbka A
    Acta Virol; 1972 Jul; 16(4):359. PubMed ID: 4403181
    [No Abstract]   [Full Text] [Related]  

  • 12. Initiation of persistent lymphocytic choriomeningitis infection in adult mice.
    Suzuki S; Hotchin J
    J Infect Dis; 1971 Jun; 123(6):603-10. PubMed ID: 4999906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Murine lymphocytic choriomeningitis: pathology of the lymphatic tissue].
    Löhler J; Ehlerding I; Lehmann-Grube F
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):458-68. PubMed ID: 4154627
    [No Abstract]   [Full Text] [Related]  

  • 14. On the induction of immunological tolerance to a self-reproducing antigen.
    Larsen JH
    Immunology; 1969 Jan; 16(1):15-23. PubMed ID: 4977003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latent infection of the Syrian hamster (Mesocricetus auratus auratus) with lymphocytic choriomeningitis virus (LCM)].
    Petrović M; Timm H
    Zentralbl Bakteriol Orig; 1968; 207(4):435-42. PubMed ID: 4987918
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease.
    Cole GA; Gilden DH; Monjan AA; Nathanson N
    Fed Proc; 1971; 30(6):1831-41. PubMed ID: 4942053
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 3. DURATION AND MAXIMAL EFFECT OF ADOPTIVE IMMUNIZATION OF VIRUS CARRIERS.
    VOLKERT M; LARSEN JH
    Acta Pathol Microbiol Scand; 1964; 60():577-87. PubMed ID: 14154720
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of transplanted lymphoid cells, irradiation, and drug therapy on permanent immunologic tolerance.
    Larsen JH
    J Immunol; 1971 Jul; 107(1):185-94. PubMed ID: 4997110
    [No Abstract]   [Full Text] [Related]  

  • 19. [The infection rate of the rural population in the Federal Republic of Germany with the lymphocytic choriomeningitis virus].
    Blumenthal W; Kessler R; Ackermann R
    Zentralbl Bakteriol Orig; 1970; 213(1):36-48. PubMed ID: 4989309
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice.
    Gilden DH; Cole GA; Monjan AA; Nathanson N
    J Exp Med; 1972 Apr; 135(4):860-73. PubMed ID: 4622912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.